Viva Biotech
Business Services · China · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
no.735 Ziping Rd, Pudong, Shanghai, 2013...Phone Number
+86 2160893288Website
www.vivabiotech.comRevenue
$332.5 MillionIndustry
About Viva Biotech
Viva Biotech Org Chart
Is Viva Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Viva Biotech is spiking on competitors!
Product Launch: Get notified when Viva Biotech launches new products
Website visits: Recent activity has been detected on your website
Check if Viva Biotech has recently received funding, and reach out quickly before it becomes old news!
Viva Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Viva Biotech has new funding data
Earning: See what the market has to say on Viva Biotech recently announced quarterly report
Click to see if Viva Biotech had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Viva Biotech
Recommended Actions
Find VP level buyers at Viva Biotech
Find more new buyers
Company Profile Activity
Activity Insights
Viva Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Viva Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Viva Biotech.
Viva Biotech financials insights
Gather financial insights about Viva Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Private Equity
$210M
Private Equity
$210M
Viva Biotech Tech Stack
A closer look at the technologies used by Viva Biotech
Most Recent Scoops
Viva Biotech News & Media
Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R&D, CDMO Commercial Manufacturing Accelerates Revenue Growth
Results Highlights for Interim Results ended 30 June 2026 Revenue reached RMB1,006.5 million, increasing by 21.0% YoY Gross profit amounted to RMB341.7 million, increasing by 0.7% YoY Gross profit margin was 34.0% HONG KONG, Aug. 26, 2026 /PRNewswire/ -- On August 26, 2026, Viva Biotech...Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up
Financial Highlights Revenue reached RMB1,729.4 million Gross profit amounted to RMB655.6 million Gross profit margin recorded 37.9%, a YOY increase of 3.3 pp Net profit recorded RMB269.3 million, a YOY increase 21.3% Adjusted non-IFRS net profit recorded RMB335.3 million, a YOY increase...Adventures in DMPK: Viva Biotech's One-Stop Pharmacology Platform Cross New Modalities
SHANGHAI, Dec. 29, 2025 /PRNewswire/ -- Drug Pharmacokinetics and Pharmacodynamics (PKPD) has become increasingly critical as drug discovery modalities continue to expand across a broader and more diverse therapeutic landscape. Viva Biotech has responded by building an integrated...Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
STOCKHOLM, Dec. 15, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (STO: SOBI) recently announced that it has entered into an acquisition agreement with Arthrosi Therapeutics, Inc., which was invested in and incubated by Viva Biotech Holdings. Under the terms of the agreement, Sobi will...
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Viva Biotech
Viva Biotech operates a leading structure-based, integrated drug discovery platform, providing structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their preclinical stage innovative drug development.... Read More
